Correlation Between Neximmune and Longboard Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Neximmune and Longboard Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neximmune and Longboard Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neximmune and Longboard Pharmaceuticals, you can compare the effects of market volatilities on Neximmune and Longboard Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neximmune with a short position of Longboard Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neximmune and Longboard Pharmaceuticals.
Diversification Opportunities for Neximmune and Longboard Pharmaceuticals
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Neximmune and Longboard is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Neximmune and Longboard Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Longboard Pharmaceuticals and Neximmune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neximmune are associated (or correlated) with Longboard Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Longboard Pharmaceuticals has no effect on the direction of Neximmune i.e., Neximmune and Longboard Pharmaceuticals go up and down completely randomly.
Pair Corralation between Neximmune and Longboard Pharmaceuticals
Given the investment horizon of 90 days Neximmune is expected to generate 2.03 times less return on investment than Longboard Pharmaceuticals. In addition to that, Neximmune is 2.89 times more volatile than Longboard Pharmaceuticals. It trades about 0.03 of its total potential returns per unit of risk. Longboard Pharmaceuticals is currently generating about 0.17 per unit of volatility. If you would invest 2,082 in Longboard Pharmaceuticals on September 22, 2024 and sell it today you would earn a total of 3,916 from holding Longboard Pharmaceuticals or generate 188.09% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 14.78% |
Values | Daily Returns |
Neximmune vs. Longboard Pharmaceuticals
Performance |
Timeline |
Neximmune |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Longboard Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Good
Neximmune and Longboard Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neximmune and Longboard Pharmaceuticals
The main advantage of trading using opposite Neximmune and Longboard Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neximmune position performs unexpectedly, Longboard Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Longboard Pharmaceuticals will offset losses from the drop in Longboard Pharmaceuticals' long position.Neximmune vs. ZyVersa Therapeutics | Neximmune vs. Palisade Bio | Neximmune vs. Unicycive Therapeutics | Neximmune vs. Immix Biopharma |
Longboard Pharmaceuticals vs. Molecular Partners AG | Longboard Pharmaceuticals vs. MediciNova | Longboard Pharmaceuticals vs. Anebulo Pharmaceuticals | Longboard Pharmaceuticals vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Fundamental Analysis View fundamental data based on most recent published financial statements |